Follow
Silvia Carloni
Silvia Carloni
Verified email at irst.emr.it
Title
Cited by
Cited by
Year
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
F Fabbri, S Carloni, W Zoli, P Ulivi, G Gallerani, P Fici, E Chiadini, ...
Cancer letters 335 (1), 225-231, 2013
2472013
Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study
F Fabbri, S Carloni, G Brigliadori, W Zoli, R Lapalombella, M Marini
BMC Cell Biology 7, 1-14, 2006
1042006
Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines
P Ulivi, C Arienti, D Amadori, F Fabbri, S Carloni, A Tesei, I Vannini, ...
Journal of cellular physiology 220 (1), 214-221, 2009
942009
Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells
F Fabbri, D Amadori, S Carloni, G Brigliadori, A Tesei, P Ulivi, M Rosetti, ...
Journal of cellular physiology 217 (2), 494-501, 2008
792008
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ...
Oncotarget 7 (14), 18424, 2016
562016
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides
A Guerrini, A Tesei, C Ferroni, G Paganelli, A Zamagni, S Carloni, ...
Journal of Medicinal Chemistry 57 (17), 7263-7279, 2014
562014
Activity of lipoplatin in tumor and in normal cells in vitro
C Arienti, A Tesei, A Ravaioli, M Ratta, S Carloni, S Mangianti, P Ulivi, ...
Anti-cancer drugs 19 (10), 983-990, 2008
482008
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
I Vannini, PM Wise, KB Challagundla, M Plousiou, M Raffini, E Bandini, ...
Nature communications 8 (1), 1801, 2017
402017
Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity
A Tesei, G Brigliadori, S Carloni, F Fabbri, P Ulivi, C Arienti, A Sparatore, ...
Journal of Cellular Physiology 227 (10), 3389-3396, 2012
352012
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia
G Musuraca, S De Matteis, R Napolitano, C Papayannidis, ...
Journal of translational medicine 13, 1-10, 2015
342015
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
F Fabbri, G Brigliadori, S Carloni, P Ulivi, I Vannini, A Tesei, R Silvestrini, ...
Journal of translational medicine 6, 1-10, 2008
322008
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer
M Montanari, F Fabbri, E Rondini, GL Frassineti, R Mattioli, S Carloni, ...
Tumori Journal 98 (6), 696-701, 2012
292012
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
T Ibrahim, L Mercatali, E Sacanna, A Tesei, S Carloni, P Ulivi, C Liverani, ...
Cancer cell international 12, 1-12, 2012
282012
Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer
S Pignatta, I Orienti, M Falconi, G Teti, C Arienti, L Medri, M Zanoni, ...
Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 263-273, 2015
272015
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial
AC Gardini, S Carloni, E Scarpi, P Maltoni, RM Dorizzi, A Passardi, ...
Oncotarget 7 (9), 10193, 2016
252016
Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells
S Carloni, F Fabbri, G Brigliadori, P Ulivi, R Silvestrini, D Amadori, W Zoli
Current Cancer Drug Targets 10 (4), 422-431, 2010
252010
Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease
A Casadei Gardini, M Aquilina, D Oboldi, A Lucchesi, S Carloni, E Tenti, ...
BMC cancer 13, 1-5, 2013
232013
SLUG silencing increases radiosensitivity of melanoma cells in vitro
C Arienti, A Tesei, S Carloni, P Ulivi, A Romeo, G Ghigi, E Menghi, ...
Cellular oncology 36, 131-139, 2013
232013
In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells
P Ulivi, C Arienti, W Zoli, M Scarsella, S Carloni, F Fabbri, A Tesei, ...
Current Cancer Drug Targets 10 (6), 600-610, 2010
182010
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines
I Vannini, W Zoli, F Fabbri, P Ulivi, A Tesei, S Carloni, G Brigliadori, ...
Anti-cancer drugs 20 (10), 918-925, 2009
152009
The system can't perform the operation now. Try again later.
Articles 1–20